FNBOSM
TAK icon

First National Bank of South Miami’s Takeda Pharmaceutical TAK Stock Holding History

First National Bank of South Miami’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-745
Closed -$15K – 278
2018
Q4 		$15K Buy
+745
New +$12.6K 0.01% 231

Other funds holding TAK

GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
AC
Adelphi Capital London, United Kingdom $3.21M AUM 121.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

First National Bank of South Miami's TAK Position: Q1 2019 in Review

First National Bank of South Miami sold out of Takeda Pharmaceutical (TAK) in Q1 2019, closing a stake of 745 shares — an estimated $15K sold.

First National Bank of South Miami first reported a position in TAK in Q4 2018 and held it in 1 quarter. The position peaked at $15K in Q4 2018. 390 funds tracked by Wall St. Rank hold TAK as of Q1 2019.

  • First National Bank of South Miami reported no remaining Takeda Pharmaceutical position as of Q1 2019 after selling out during the quarter.
  • First National Bank of South Miami sold 745 Takeda Pharmaceutical shares in Q1 2019, an estimated $15K.
  • First National Bank of South Miami first reported a position in Takeda Pharmaceutical in Q4 2018 and held it in 1 quarter.
  • First National Bank of South Miami's Takeda Pharmaceutical position peaked at $15K in Q4 2018.
  • 390 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2019.

Based on First National Bank of South Miami's 13F filing for Q1 2019, filed 26 Apr 2019.